ストックスクリーナーアプリを入手
9.49
12.13%
-1.31
アフターアワーズ：
9.26
-0.23
-2.42%
前日終値:
$10.80
開ける：
$11.11
24時間の取引高:
334.18K
Relative Volume:
8.66
時価総額：
$253.94M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-13.10%
1か月 パフォーマンス:
-37.75%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$9.25
$11.51
1週間の範囲:
$9.25
$11.51
52週間の値動き範囲:
$9.25
$18.79
Conexeu Sciences Inc Stock (CNXU) Company Profile
名前
Conexeu Sciences Inc
セクター
電話
604-315-4722
住所
50 WEST LIBERTY STREET, SUITE 880, RENO
Compare CNXU vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNXU
Conexeu Sciences Inc
|
9.49 | 288.99M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Conexeu Sciences Inc (CNXU) 最新ニュース
Conex Completes 12-Month P.R.O.O.F Preclinical Study, Targets Q1 2027 510(k) for Wound Care - TradingView
[8-K] Conexeu Sciences Inc. Reports Material Event - Stock Titan
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It - PR Newswire
Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeat
Conexeu Sciences (CNXU) Insider Trading Activity 2026 - MarketBeat
Enterprise value to EBITDA forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Conexeu Sciences (CNXU) Earnings Date and Reports 2026 - MarketBeat
Conexeu Sciences Inc. Common Stock (NASDAQ: CNXU) Stock Price, News & Analysis - Kalkine
Price to book forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Enterprise value to revenue forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Price to sales forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity - Investing News Network
CNXU News Today | Why did Conexeu Sciences stock go up today? - MarketBeat
Conexeu Sciences (CNXU) Stock Forecast and Price Target 2026 - MarketBeat
Conexeu Sciences : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
50,000 options reported by Conexeu Sciences (CNXU) director - Stock Titan
Conexeu Sciences (CNXU) 10K Form and Latest SEC Filings 2026 - MarketBeat
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CNXU Forecast — Price Target — Prediction for 2027 - TradingView
Conexeu Sciences, Inc. Actuals & Estimates (NASDAQ:CNXU) - TradingView
Conexeu Sciences (CNXU) Stock Trends and Sentiment 2026 - MarketBeat
Conexeu Sciences opens R&D facility in Vancouver - Investing.com
The Aesthetics Giants Just Confirmed "Ozempic Face" Is Realand a Newly Public Regenerative Player Wants to Compete for It - Investing News Network
Conexeu Sciences opens R&D facility in Vancouver By Investing.com - Investing.com Australia
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform - The Manila Times
Conexeu Launches R&D Facility at M4 to Innovate Wound Healing Tech - techcouver.com
Conexeu Sciences Inc.: Target Price Consensus and Analysts Recommendations | CNXU | US20715F1003 - marketscreener.com
Conexeu Sciences (CNXU) director holds 50K options at $2.30, 2031 expiry - Stock Titan
Conexeu Sciences aims for FDA clearance by 2027 with a promising regenerative medicine product. - Pluang
Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission - Seeking Alpha
Insider Stock Purchases: June 24, 2026 - Moomoo
TradingKey - TradingKey
Conexeu Sciences Ord Shs (CNXU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Conexeu Sciences Ord Shs (CNXU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Conexeu Sciences Ord Shs (CNXU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Conexeu Sciences Ord Shs (CNXU) Valuation: PE, PB & Fair Value Analysis - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.860|Chg%:0.60 - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.360|Chg%:-0.33 - TradingKey
Conexeu Sciences Ord Shs (CNXU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Conexeu Sciences Ord Shs (CNXU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Conexeu Sciences Ord Shs (CNXU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CNXU|Conexeu Sciences Ord Shs|Price:10.820|Chg%:0.27 - TradingKey
[Form 3] Conexeu Sciences Inc. Initial Statement of Beneficial Ownership - Stock Titan
Insider at Conexeu Sciences (CNXU) adds common stock and warrants - Stock Titan
Homegrown biotech firm launches new R&D lab space in Vancouver - Business in Vancouver
This Credo Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
H.C. Wainwright Initiates Conexeu Sciences(CNXU.US) With Buy Rating, Announces Target Price $20 - Moomoo
Conexeu Sciences (CNXU) 10% owner exercises 250K warrants via N3GU - Stock Titan
Conexeu Sciences initiated with a Buy at H.C. Wainwright - TipRanks
CNXU Initiates Coverage by HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
Conexeu Sciences stock initiated at buy by H.C. Wainwright, $20 target - Investing.com South Africa
Conexeu Sciences Inc (CNXU) 財務データ
Conexeu Sciences Inc (CNXU) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):